Nighthawk Biosciences' Scorpion Subsidiary Announces Grand Opening of its San Antonio Facility
bdtonline.com
news
2022-10-21 12:03:13

DURHAM, N.C., Oct. 21, 2022 (GLOBE NEWSWIRE) -- NightHawk Biosciences Â (NYSE American: NHWK), a fully integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that its Scorpion subsidiary plans to host the grand opening of its San Antonio facility today, October 21.David Halverson, President of Scorpion, commented, 'We are pleased with the recent FDA feedback regarding our design, operational strategy, and environmental controls relevant to clinical and commercial manufacturing at our San Antonio facility.
